Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BioRay Approved to Launch Anruixi, a CD20 mAb, for B-Cell Lymphoma in China

publication date: Sep 13, 2023

Zhejiang BioRay Pharma was approved for a China launch of its Class I innovative therapeutic biological product, zuberitamab injection (Anruixi®), to treat CD20-positive diffuse large B-cell lymphoma. Anruixi is China's first CD20 Class I mAb. It targets CD20 on the surface of B-cell, leading to B-cell elimination via ADCC and CDC. The company believes its product has a stronger ADCC effect than the competition. Anruixi is the first China-developed Class I anti-CD20 drug approved for China use and BioRay’s sixth marketed product. BioRay is conducting trials of Anruixi for autoimmune diseases, including primary immune thrombocytopenia. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here